BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36755294)

  • 1. Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
    Zwimpfer TA; Schwab FD; Steffens D; Kaul F; Schmidt N; Geiger J; Geissler F; Heinzelmann-Schwarz V; Weber WP; Kurzeder C
    World J Surg Oncol; 2023 Feb; 21(1):40. PubMed ID: 36755294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
    Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
    Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.
    Tokmak H; Kaban K; Muslumanoglu M; Demirel M; Aktan S
    World J Surg Oncol; 2014 Jul; 12():205. PubMed ID: 25016393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence.
    Sato A; Sakai T; Iwase T; Kano F; Kimura K; Ogiya A; Koizumi M; Tanabe M; Horii R; Akiyama F; Ueno T; Ohno S
    Radiat Oncol; 2019 Sep; 14(1):159. PubMed ID: 31477153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contralateral Axillary Lymph Node Metastasis in a Patient with Relapsed Breast Cancer: Locoregional Event or Distant Metastasis Disease?
    Herrera-Martínez Y; Acevedo-Bañez I; De-Bonilla-Damiá Á; Fernández-Rodríguez P; Sousa JM; Jiménez-Hoyuela García JM
    Oncol Res Treat; 2021; 44(3):128-131. PubMed ID: 33440391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous contralateral axillary lymph node metastasis in a recurrent breast cancer following previous axillary clearance.
    Goh IY; Dauway EL
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral lymph node recurrence in breast cancer: Regional event rather than distant metastatic disease. A systematic review of the literature.
    Moossdorff M; Vugts G; Maaskant-Braat AJ; Strobbe LJ; Voogd AC; Smidt ML; Nieuwenhuijzen GA
    Eur J Surg Oncol; 2015 Sep; 41(9):1128-36. PubMed ID: 26108737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature.
    Ge I; Erbes T; Juhasz-Böss I
    Arch Gynecol Obstet; 2022 Oct; 306(4):943-957. PubMed ID: 35122159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel Lymph Node Dissection in Locally Recurrent Breast Cancer.
    Uth CC; Christensen MH; Oldenbourg MH; Kjær C; Garne JP; Teilum D; Kroman N; Tvedskov TF
    Ann Surg Oncol; 2015 Aug; 22(8):2526-31. PubMed ID: 25564177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).
    de Wild SR; van Roozendaal LM; de Wilt JHW; van Dalen T; van der Hage JA; van Duijnhoven FH; Simons JM; Schipper RJ; de Munck L; van Kuijk SMJ; Boersma LJ; Linn SC; Lobbes MBI; Poortmans PMP; Tjan-Heijnen VCG; van de Vijver KKBT; de Vries J; Westenberg AH; Strobbe LJA; Smidt ML
    Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38597154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer.
    Agarwal A; Heron DE; Sumkin J; Falk J
    J Surg Oncol; 2005 Oct; 92(1):4-8. PubMed ID: 16180213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
    Agresti R; Crippa F; Sandri M; Martelli G; Tagliabue E; Alessi A; Pellitteri C; Maccauro M; Maugeri I; Barbara P; Rampa M; Moscaroli A; Ferraris C; Carcangiu ML; Bianchi G; Greco M; Bombardieri E
    Breast; 2014 Aug; 23(4):334-40. PubMed ID: 24485802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of Recurrent Breast Cancer with Contralateral Axillary Node Recurrence Cured after Mastectomy for Ipsilateral Breast Tumor Recurrence].
    Nakakuma T; Takahashi K; Ueno S; Tabei T; Inada T; Kondou Y; Kosaka Y; Sengoku N
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2018-2020. PubMed ID: 32157045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer.
    Sood A; Youssef IM; Heiba SI; El-Zeftawy H; Axelrod D; Seigel B; Mills C; Abdel-Dayem HM
    Clin Nucl Med; 2004 Nov; 29(11):698-702. PubMed ID: 15483481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inguinal Sentinel Lymph Node in a Patient With Recurrent Breast Cancer.
    Álvarez-Moreno M; Álvarez-Santos J; Manzarbeitia-Arroba B; Balsa-Bretón MÁ; Sandoval-Moreno C
    Clin Nucl Med; 2023 Mar; 48(3):e143-e144. PubMed ID: 36723901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.